Immunic, Inc. (IMUX) Financials

IMUX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 54.3 million 25.4 million
2023-09-30 67.0 million 18.6 million
2023-06-30 88.7 million 19.5 million
2023-03-31 108.9 million 17.7 million

IMUX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.2 million 1.6 million
2023-09-30 -17.4 million 1.7 million
2023-06-30 -20.0 million 1.8 million
2023-03-31 -19.6 million 2.0 million

IMUX Net Income

No data available :(

IMUX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 46.7 million - 1.3 million
2023-09-30 59.7 million - 1.5 million
2023-06-30 77.3 million - 1.9 million
2023-03-31 97.1 million - 1.4 million

IMUX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 44.3 billion
2023-09-30 44.6 million
2023-06-30 44.4 million
2023-03-31 43.7 million

IMUX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 165000 19.3 million 7.9 million 3.8 million
2023-09-30 44000 19.8 million 3.8 million -
2023-06-30 21000 21.2 million 3.8 million -
2023-03-31 104000 23.0 million 4.3 million -

IMUX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 34000
2023-06-30 - 22000
2023-03-31 - 32000

IMUX

Price: $1.37

52 week price:
0.95
3.11

Earnings Per Share: -2.11 USD

P/E Ratio: -0.38

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 562646

Market Capitalization: 116.0 million

Links: